	Quiver Bioscience Secures Non-Dilutive Funding to Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities and Advance Powerful AI/ML-Based In Vitro / In ... - Morningstar
	Polyrizon Ltd. Reports Promising Preclinical Results for CNS Drug Delivery Using Hydrogel-Based Trap ' Target Platform - Nasdaq
	CNS oligonucleotide licensing deals continue to soar
	Bexorg enters research collaboration with Biohaven leveraging its novel AI-driven whole-brain discovery platform to enhance CNS drug development
	Headlands Research acquires San Juan-based CMRCenter to expand trials
	New partnership targets CNS symptoms in ultra-rare diseases
	MIRA Reports Up to 30% Weight Loss and Reversal of High-Calorie and Nicotine Cravings in an Animal Model of Obesity and Craving Using SKNY-1, a Drug Candidate Under Definitive ...
	Bayer seeks US FDA approval for contrast agent, gadoquatrane for contrast-enhanced MRI of the CNS and other body regions